Neogen Corporation is recalling Thyrocryn and ThyroKare (levothyroxine sodium) tablets, 0.2 mg, used to treat hypothyroidism in dogs. Stability testing revealed that one batch of the medication was subpotent, meaning it contained less of the active ingredient than required, and additional batches are being removed as part of an investigation. Low potency medication can lead to under-treatment of a dog's thyroid condition.
The tablets may not provide the full dose of levothyroxine sodium required to manage a dog's thyroid condition, potentially leading to persistent symptoms of hypothyroidism. No incidents or injuries have been reported to date.
You have 2 options:
Net Contents: 180 or 1000 tablets per bottle. NADA 141-539. Manufactured for Aspen Veterinary Resources, LTD.
Net Contents: 180 or 1000 tablets per bottle. NADA 141-539. Manufactured by Neogen Corporation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response